characteristics.text: SAMN42786823
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-24T16:10:36.617Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-09-24T08:20:02.893Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22170284
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22170284
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_CAPOX_BETR
characteristics.characteristic: biospecimen repository
characteristics.text: Pt24_C1D1
characteristics.characteristic: biospecimen repository sample id
characteristics.text: BLOOD/PLASMA
characteristics.characteristic: body site
characteristics.text: phs003706
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: HMB
characteristics.characteristic: gap_consent_short_name
characteristics.text: 6237311
characteristics.characteristic: gap_sample_id
characteristics.text: 4967891
characteristics.characteristic: gap_subject_id
characteristics.text: No
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Esophageal Neoplasms
characteristics.characteristic: study disease
characteristics.text: Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma
characteristics.characteristic: study name
characteristics.text: Yes
characteristics.characteristic: subject is affected
characteristics.text: Pt24_C1D1
characteristics.characteristic: submitted sample id
characteristics.text: Pt24
characteristics.characteristic: submitted subject id
characteristics.text: NCI_CAPOX_BETR
characteristics.characteristic: submitter handle
characteristics.text: Non-tumor DNA sample from BLOOD/PLASMA of a human male participant in the dbGaP study "Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma"
characteristics.characteristic: title